EUVIMEDEUVIMED entdecken
Leserbrief

Re-evaluating Severe Cutaneous Adverse Events to Enfortumab Vedotin: TEC rather than TEN

Rentao Yu, Ling Gu, Qian Wu, Yun Pan, Fengzeng Li, Aijun Chen

Journal of the American Academy of Dermatology · 2026-10

DOI: 10.1016/j.jaad.2026.09.128 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the American Academy of Dermatology, 2026-10. Verfasst von Rentao Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Gefördert von: Bethune Charitable Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Stevens-Johnson syndromeenfortumab vedotintoxic epidermal necrolysistoxic erythema of chemotherapyurothelial carcinoma

Autor:innen und Institutionen

  • The Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • The Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China; The Department of Dermatology, The ChenJiaqiao Hospital of Shapingba Distict of Chongqing, Chongqing, China.
  • The Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China; The Department of Dermatology, Chongqing Nanchuan District People's Hospital, Chongqing, China.
  • The Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Electronic address: chenaijun@hospital.cqmu.edu.cn.

Förderung

  • Bethune Charitable Foundation

Zitieren

APA

Yu, R., Gu, L., Wu, Q., Pan, Y., Li, F., & Chen, A. (2026). Re-evaluating Severe Cutaneous Adverse Events to Enfortumab Vedotin: TEC rather than TEN. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.09.128

Vancouver

Yu R, Gu L, Wu Q, Pan Y, Li F, Chen A. Re-evaluating Severe Cutaneous Adverse Events to Enfortumab Vedotin: TEC rather than TEN. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.09.128

BibTeX
@article{Yu2026,
  author = {Yu, Rentao and Gu, Ling and Wu, Qian and Pan, Yun and Li, Fengzeng and Chen, Aijun},
  title = {Re-evaluating Severe Cutaneous Adverse Events to Enfortumab Vedotin: TEC rather than TEN},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  doi = {10.1016/j.jaad.2026.09.128}
}
Kostenlos starten →